• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [16962 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Meniscal allograft transplantation for post-meniscectomy syndrome
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Baroreceptor activation therapy for treatment-resistant hypertension
2018     NIHR Health Technology Assessment programme The Patient Centred Assessment Method for improving nurse-led biopsychosocial assessment of patients with long-term conditions: a feasibility RCT
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Carbon ion beam radiotherapy (CIRT) for cancer treatment: a systematic review of effectiveness and safety for 12 oncologic indications
2018     NIHR Health Technology Assessment programme Multiple-frequency bioimpedance devices for fluid management in people with chronic kidney disease receiving dialysis: a systematic review and economic evaluation
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Nivolumab (Opdivo®) in combination with ipilimumab (Yervoy®) for the first-line treatment of patients with advanced RCC
2018     NIHR Health Technology Assessment programme Self-care support for children and adolescents with long-term conditions: the REfOCUS evidence synthesis
2018     NIHR Health Technology Assessment programme Therapy interventions for children with neurodisabilities: a qualitative scoping study
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pembrolizumab (Keytruda®) in combination with chemotherapy for the treatment of metastatic non-small-cell lung cancer (NSCLC)
2018     NIHR Health Technology Assessment programme Axitinib, cabozantinib, everolimus, nivolumab, sunitinib and best supportive care in previously treated renal cell carcinoma: a systematic review and economic evaluation
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) External stimulation of the trigeminal nerve for the prevention and acute treatment of episodic and chronic migraine
2018     NIHR Health Technology Assessment programme The West Midlands ActiVe lifestyle and healthy Eating in School children (WAVES) study: a cluster randomised controlled trial testing the clinical effectiveness and cost-effectiveness of a multifaceted obesity prevention intervention programme targeted at children aged 6-7 years
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) PET/PET-CT Evidence for need based planning in Germany and Austria
2018     NIHR Health Technology Assessment programme Computerised interpretation of the fetal heart rate during labour: a randomised controlled trial (INFANT)
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Supporting children who have parents with mental disorders in Tyrol: A mapping of existing Tyrolean support and societal structures
2018     NIHR Health Services and Delivery Research programme Predictive risk stratification model: a randomised stepped-wedge trial in primary care (PRISMATIC)
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Prevalence of mental disorders and uptake of mental health services in Tyrol: An analysis of epidemiological literature and administrative data from the Tyrolean health insurance
2018     NIHR Health Services and Delivery Research programme Clinical leadership in service redesign using Clinical Commissioning Groups: a mixed-methods study
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Inhalation sedation with laughing gas (N2O) in dentistry – organisational and professional aspects and a systematic review of efficacy and safety
2018     NIHR Public Health Research (PHR) programme Cluster randomised controlled trial and economic and process evaluation to determine the effectiveness and cost effectiveness of a novel intervention [Healthy Lifestyles Programme (HeLP)] to prevent obesity in school children
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Drug reimbursement in the inpatient sector in Austria: Approaches for a transparent and evidence-based process, taking into account international experience
2018     NIHR Public Health Research (PHR) programme Collaborative case management to aid return to work after long-term sickness absence: a pilot randomised controlled trial
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Enzalutamide (Xtandi®) in patients with nonmetastatic, castration-resistant prostate cancer (CRPC)
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Ibrutinib (Imbruvica®) in combination with rituximab for the treatment of Waldenström’s macroglobulinaemia
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk. Update 2018
2018     NIHR Health Technology Assessment programme A randomised controlled trial and economic evaluation of intraoperative cell salvage during caesarean section in women at risk of haemorrhage: the SALVO (cell SALVage in Obstetrics) trial
2018     Health Quality Ontario (HQO) Bilateral Cochlear Implantation: A Health Technology Assessment
2018     Center for Evidence-based Practice (CEP) Palliative care in the outpatient setting for patients with heart failure or advanced lung disease
2018     Center for Evidence-based Practice (CEP) Management structures for hospital nursing
2018     Center for Evidence-based Practice (CEP) Treatment of severe acute medical-psychiatric comorbidity in hospitalized patients
2018     Center for Evidence-based Practice (CEP) Diagnosis and treatment of gastrointestinal bleeding in patients with left ventricular assist devices
2018     Center for Evidence-based Practice (CEP) Cognitive therapy for schizophrenia
2018     Andalusian Health Technology Assessment Area (AETSA) Electrical stimulation of peripheral nerves for treating chronic refractory pain
2018     Center for Evidence-based Practice (CEP) Nurse-directed discontinuation of continuous ECG monitoring among non-ICY inpatients
2018     Andalusian Health Technology Assessment Area (AETSA) Digital tomosynthesis in breast cancer. Meta-analysis
2018     Andalusian Health Technology Assessment Area (AETSA) Bibliographic review on the diagnosis, treatment and follow-up of Kawasaki disease
2018     Andalusian Health Technology Assessment Area (AETSA) 18F-FDG PET in early diagnosis of degenerative diseases of the central nervous system
2018     Andalusian Health Technology Assessment Area (AETSA) Prognostic genomic tests in early breast cancer: up-date of evidence.
2018     Andalusian Health Technology Assessment Area (AETSA) Alectinib as monotherapy for the firstline treatment of adult patients with ALKpositive advanced non-small cell lung cancer. EUnetHTA adopted HTA report
2018     Andalusian Health Technology Assessment Area (AETSA) Midostaurin with standard chemotherapy in FLT3-positive acute myeloid leukaemia. EUnetHTA adopted HTA report.
2018     Andalusian Health Technology Assessment Area (AETSA) Quality criteria and good practices in organizations dedicated to the Health Technologies Assessment
2018     Andalusian Health Technology Assessment Area (AETSA) Regorafenib indicated as monotherapy for the treatment of adult patients with hepatocellular carcinoma who have been previously treated with sorafenib. EUnetHTA adopted HTA report.
2018     Health Quality Ontario (HQO) Portable ultraviolet light surface-disinfecting devices for prevention of hospital-acquired infections: a healthtechnology assessment
2018     Health Quality Ontario (HQO) Continuous monitoring of glucose for Type 1 Diabetes: a health technology assessment
2018     Health Quality Ontario (HQO) Portable ultraviolet light surface-disinfecting devices for prevention of hospital-acquired infections: OHTAC recommendation
2018     Health Quality Ontario (HQO) Continuous monitoring of glucose for Type 1 diabetes: OHTAC recommendation
2018     Adelaide Health Technology Assessment (AHTA) Processing and cryopreservation of ovarian tissue prior to or after gonadotoxic treatment to preserve fertility in females for the future
2018     Adelaide Health Technology Assessment (AHTA) Systematic literature review on the association between alcohol consumption and mental health disorders. Evidence Evaluation Report
2018     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [TIDY program. Therapeutic Identification of depression in Young people.]
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Abemaciclib (Verzenio®) in combination with a nonsteroidal aromatase inhibitor (NSAI) as initial therapy for advanced breast cancer (ABC)
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Rituximab (MabThera®) after autologous stem-cell transplantation (ASCT) in mantle cell lymphoma (MCL)
2018     Health Technology Wales (HTW) FreeStyle Libre flash glucose monitoring for the management of type 1 or type 2 diabetes
2018     NIHR Health Technology Assessment programme Combining optical coherence tomography with visual field data to rapidly detect disease progression in glaucoma: a diagnostic accuracy study
2018     Belgian Health Care Knowledge Centre (KCE) Responsible use of high-risk medical devices: the example of 3D printed medical devices
2018     National Authority for Assessment and Accreditation in Healthcare (INEAS) Le trastuzumab dans le traitement du cancer du sein HER2 positif au stade précoce et localement avancé 
2018     Health Quality Ontario (HQO) Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment
2018     Health Quality Ontario (HQO) Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment
2018     Health Quality Ontario (HQO) Magnetic Resonance-Guided Focused Ultrasound Neurosurgery for Essential Tremor: A Health Technology Assessment
2018     Health Quality Ontario (HQO) Structured Education and Neuromuscular Exercise Program for Hip and/or Knee Osteoarthritis: A Health Technology Assessment
2018     Adelaide Health Technology Assessment (AHTA) Systematic literature review on the association between alcohol consumption and mental health disorders. Technical Report
2018     Health Quality Ontario (HQO) Electronic Monitoring Systems to Assess Urinary Incontinence: A Health Technology Assessment
2018     NIHR Health Technology Assessment programme The UK EndoVascular Aneurysm Repair (EVAR) randomised controlled trials: long-term follow-up and cost-effectiveness analysis
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Echocardiography: Guideline recommendations and options to identify inappropriate use as well as usage rate in Austria
2018     Basque Office for Health Technology Assessment (OSTEBA) HIFU —High intensity focused ultrasound— in essential tremor
2018     NIHR Health Technology Assessment programme PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer
2018     Belgian Health Care Knowledge Centre (KCE) MammaPrint® test for personalised management of adjuvant chemotherapy decisions in early breast cancer
2018     NIHR Health Services and Delivery Research programme Understanding new models of integrated care in developed countries: a systematic review
2018     NIHR Health Services and Delivery Research programme A staff training intervention to improve communication between people living with dementia and health-care professionals in hospital: the VOICE mixed-methods development and evaluation study
2018     NIHR Health Technology Assessment programme Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review
2018     NIHR Health Technology Assessment programme What works to increase attendance for diabetic retinopathy screening? An evidence synthesis and economic analysis
2018     NIHR Health Technology Assessment programme The future for diagnostic tests of acute kidney injury in critical care: evidence synthesis, care pathway analysis and research prioritisation
2018     NIHR Health Technology Assessment programme Screening women aged 65 years or over for abdominal aortic aneurysm: a modelling study and health economic evaluation
2018     NIHR Health Technology Assessment programme Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis
2018     NIHR Health Technology Assessment programme Therapeutic hypothermia to reduce intracranial pressure after traumatic brain injury: the Eurotherm3235 RCT
2018     NIHR Health Technology Assessment programme Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: a systematic review and cost-effectiveness analysis
2017     NIHR Health Technology Assessment programme A randomised controlled study of the effectiveness of breathing retraining exercises taught by a physiotherapist either by instructional DVD or in face-to-face sessions in the management of asthma in adults
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Lonoctocog alfa (haemophilia A) - benefit assessment according to §35a Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Atezolizumab (urothelial carcinoma, first-line treatment) - benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of surgical options for the management of anterior and/or posterior vaginal wall prolapse: two randomised controlled trials within a comprehensive cohort study results from the PROSPECT Study
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pembrolizumab (non-small cell lung cancer) - benefit assessment according to §35a Social Code Book V ]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Atezolizumab (urothelial carcinoma) - benefit assessment according to §35a Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ixekizumab (plaque psoriasis) - benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme A multicentre, randomised controlled trial of position during the late stages of labour in nulliparous women with an epidural: clinical effectiveness and an economic evaluation (BUMPES)
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Secukinumab (plaque psoriasis) - benefit assessment according to §35a Social Code Book V (new scientific findings)]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cabozantinib (Nierenzellkarzinom) - addendum to order A16-69]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Elosulfase alfa (mucopolysaccharidosis type IVA) - assessment according to §35a (para. 1, sentence 11) Social Code Book V (new scientific findings)]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Palbociclib (breast cancer) - addendum to commission A16-74]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Obeticholic acid (primary biliary cholangitis) – assessment according to § 35a (para. 1, sentence 10) Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ixazomib (multiple myeloma) – assessment according to § 35a (para. 1, sentence 10) Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Procedure for lung volume reduction in severe lung emphysema]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Analysis of clinical studies of medical devices]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Extracorporeal shock wave therapy (ESWT) for heel pain]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for malignant neoplasms of the pancreas – addendum to commission H16-02C]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Active knee motion devices in the treatment of anterior cruciate ligament ruptures]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for secondary malignant neoplasms of the liver and the intrahepatic bile ducts – addendum to commission H16-02E]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Guideline synopsis for a DMP "Depression"]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Update of the guideline synopsis for the DMP "rheumatoid arthritis" - rapid report]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ribociclib (breast cancer) - benefit assessment according to §35a Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pembrolizumab (urothelial carcinoma) - benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme Support and Assessment for Fall Emergency Referrals (SAFER) 2: a cluster randomised trial and systematic review of clinical effectiveness and cost-effectiveness of new protocols for emergency ambulance paramedics to assess older people following a fall with referral to community-based care when appropriate